Ribeiro, Susan Pereira; Mattaraia, Vania Gomes de Moura; Almeida, Rafael Ribeiro 
; Valentine, Elizabeth Juliana Ghiuro; Sales, Natiely Silva; Ferreira, Luís Carlos de Souza ; Rocha, Luiz Carlos de Sá; Jacintho, Lucas Cauê; Santana, Vinicius Canato; Sidney, John; Sette, Alessandro; Rosa, Daniela Santoro ; Kalil Filho, Jorge Elias ; Cunha Neto, Edecio
Fonte: Vaccine. Unidades: ICB, FMVZ, FM
Assuntos: VACINAS VIRAIS, HIV, LINFÓCITOS T, EPITOPOS, PRIMATAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Susan Pereira et al. A promiscuous T cell epitope-based HIV vaccine providing redundant population coverage of the HLA class II elicits broad, polyfunctional T cell responses in nonhuman primates. Vaccine, v. 40, n. 2, p. 239-246, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2021.11.076. Acesso em: 19 abr. 2024.APA
Ribeiro, S. P., Mattaraia, V. G. de M., Almeida, R. R., Valentine, E. J. G., Sales, N. S., Ferreira, L. C. de S., et al. (2022). A promiscuous T cell epitope-based HIV vaccine providing redundant population coverage of the HLA class II elicits broad, polyfunctional T cell responses in nonhuman primates. Vaccine, 40( 2), 239-246. doi:10.1016/j.vaccine.2021.11.076NLM
Ribeiro SP, Mattaraia VG de M, Almeida RR, Valentine EJG, Sales NS, Ferreira LC de S, Rocha LC de S, Jacintho LC, Santana VC, Sidney J, Sette A, Rosa DS, Kalil Filho JE, Cunha Neto E. A promiscuous T cell epitope-based HIV vaccine providing redundant population coverage of the HLA class II elicits broad, polyfunctional T cell responses in nonhuman primates [Internet]. Vaccine. 2022 ; 40( 2): 239-246.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1016/j.vaccine.2021.11.076Vancouver
Ribeiro SP, Mattaraia VG de M, Almeida RR, Valentine EJG, Sales NS, Ferreira LC de S, Rocha LC de S, Jacintho LC, Santana VC, Sidney J, Sette A, Rosa DS, Kalil Filho JE, Cunha Neto E. A promiscuous T cell epitope-based HIV vaccine providing redundant population coverage of the HLA class II elicits broad, polyfunctional T cell responses in nonhuman primates [Internet]. Vaccine. 2022 ; 40( 2): 239-246.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1016/j.vaccine.2021.11.076
